Bayforest Capital’s Boston Scientific BSX Stock Holding History

Bayforest Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-652	Closed	-$62.2K	–	912
2025 Q4	$62.2K	Sell	652 -942	-59%	-$92.4K	0.05%	557
2025 Q3	$156K	Sell	1,594 -669	-30%	-$69.3K	0.07%	440
2025 Q2	$243K	Buy	2,263 +1,893	+512%	+$192K	0.11%	340
2025 Q1	$37.3K	Sell	370 -194	-34%	-$19.5K	0.02%	591
2024 Q4	$50.4K	Buy	+564	New	+$49.6K	0.06%	471

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bayforest Capital's BSX Position: Q1 2026 in Review

Bayforest Capital sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 652 shares — an estimated $62.2K sold.

Bayforest Capital first reported a position in BSX in Q4 2024 and held it in 5 quarters. The position peaked at $243K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Bayforest Capital reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Bayforest Capital sold 652 Boston Scientific shares in Q1 2026, an estimated $62.2K.
Bayforest Capital first reported a position in Boston Scientific in Q4 2024 and held it in 5 quarters.
Bayforest Capital's Boston Scientific position peaked at $243K in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Bayforest Capital's 13F filing for Q1 2026, filed 15 Apr 2026.